Sharon Jones Is Once Again Battling Cancer | Under the Radar Magazine Under the Radar | Music Blog for the Indie Music Magazine
Wednesday, February 21st, 2024  

Sharon Jones Is Once Again Battling Cancer

"I'm gonna keep fighting. We got a long way to go."

Sep 14, 2015 Sharon Jones & the Dap-Kings
Bookmark and Share

Back in 2013 Sharon Jones (of Sharon Jones & the Dap-Kings) was diagnosed with stage one bile duct cancer, which was later re-diagnosed as stage two pancreatic cancer. It led to the postponement of the band’s fifth album, Give the People What They Want, which then came out the following year. Jones fought the cancer hard and following surgery and treatment was well enough to get back on the road. Alas, we now have the sad news that her cancer has returned. Jones announced the news during a Friday appearance at the Toronto Film Festival, where a documentary on her, Miss Sharon Jones! (directed by Barbara Kopple) was screening. The documentary is about her initial battle with cancer and her return to the stage. At the screening, as Indiewire reports, Jones was joined onstage by her oncologist Dr. James Leonardo, and announced that her cancer was back saying: “I start chemo on Wednesday. But I’m gonna keep fighting. We got a long way to go.” Then at a Sunday screening for the film The Toronto Star reports that Jones said: “I’m going to do what I have to do. I’m going to sing.”

Sharon Jones & the Dap-Kings are releasing a holiday record, It’s a Holiday Soul Party, on October 30 via Daptone. Below is the video for Give the People What They Want single “Stranger to My Happiness.” Also read our 2014 print article on Jones and her original cancer fight, as well as our longer 2014 Q&A interview with her. We wish Jones the best of health and a speedy recovery.

(Via Pitchfork)


Submit your comment

Name Required

Email Required, will not be published


Remember my personal information
Notify me of follow-up comments?

Please enter the word you see in the image below:

There are no comments for this entry yet.